Janux Therapeutics
Janux Therapeutics is seeking a Principal Scientist to lead and oversee analytical and formulation development activities for therapeutic candidates in immuno-oncology and autoimmune disease. The role requires deep expertise in analytical methodologies, biologics formulation, and regulatory requirements, along with experience managing activities at CDMOs. This position involves technical leadership, cross-functional collaboration, and mentorship to advance projects from early development through commercialization.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Janux Therapeutics is a biotechnology company developing precision‑engineered T cell immunotherapies. They design novel therapeutics that selectively modulate T cells to treat cancer and autoimmune diseases while minimizing systemic safety issues. Their approach focuses on targeted modulation of immune responses to improve efficacy and reduce toxicity. Janux aims to translate selective T‑cell control into safer, more effective immunotherapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Janux Therapeutics.
22% above the average for this role
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
1 month ago
Senior Scientist
Nurix
Senior Scientist, Analytical Development and Quality Control (Drug Product)
Nurix
Senior Associate Scientist, Formulation Development (Peptide and Antibody)
Regeneron Pharmaceuticals
Scientific Director, Analytical Development
Neurocrine Biosciences
Senior Formulation Scientist
Hims
Director, Drug Product Development
Iambic Therapeutics